Published in Diabetes Care on July 01, 2010
Energy Balance Following Islet Transplantation (EBFIT) | NCT03063229
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes. Diabetes Care (2010) 1.29
The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol (2011) 1.12
The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord (2012) 1.06
Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care (2013) 1.03
Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review. Cardiovasc Diabetol (2013) 0.97
Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care (2012) 0.96
We can change the natural history of type 2 diabetes. Diabetes Care (2014) 0.91
Proinflammatory and prothrombotic effects of hypoglycemia. Diabetes Care (2010) 0.91
Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol (2011) 0.90
Hypoglycemia as a driver of cardiovascular risk in diabetes. Curr Atheroscler Rep (2013) 0.89
Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans. Diabetes (2015) 0.88
Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes. Diabetes Technol Ther (2012) 0.87
Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings. J Diabetes Sci Technol (2015) 0.85
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). Am J Cardiol (2014) 0.84
Hypoglycemia in Type 2 Diabetes--More Common Than You Think: A Continuous Glucose Monitoring Study. J Diabetes Sci Technol (2015) 0.84
Performance of a Blood Glucose Monitoring System in a Point-of-Care Setting. J Diabetes Sci Technol (2016) 0.83
Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther (2012) 0.81
Mechanisms of hypoglycemia and exercise-associated autonomic dysfunction. Trans Am Clin Climatol Assoc (2014) 0.80
How to best manage glycemia and non-glycemia during the time of acute myocardial infarction. Diabetes Technol Ther (2012) 0.80
Importance of hypoglycemia on the risk of Alzheimer's disease in elderly subjects with diabetes mellitus. Clin Interv Aging (2015) 0.78
Cerebral ischemic damage in diabetes: an inflammatory perspective. J Neuroinflammation (2017) 0.78
Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk. Cardiovasc Diabetol (2015) 0.77
All-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A(1c), systolic blood pressure, and low-density lipoprotein cholesterol levels. PLoS One (2014) 0.77
Hypoglycemia and vascular disease. Clin Chem (2010) 0.76
A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic Range. J Diabetes Sci Technol (2016) 0.75
Association of self-reported recurrent mild hypoglycemia with incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes: Prospective analysis of the Joint Asia Diabetes Evaluation Registry. Medicine (Baltimore) (2016) 0.75
Update on strategies limiting iatrogenic hypoglycemia. Endocr Connect (2015) 0.75
Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control. Diabetes (2015) 0.75
Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans. J Diabetes Complications (2016) 0.75
Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus. Sci Rep (2017) 0.75
Dynamin-Related Protein 1 Mediates Low Glucose-Induced Endothelial Dysfunction in Human Arterioles. Am J Physiol Heart Circ Physiol (2016) 0.75
The role of bile acid sequestrants in the management of type 2 diabetes mellitus. Metab Syndr Relat Disord (2010) 0.75
Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes. Metabolism (2016) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol (1979) 27.52
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Inflammation and atherosclerosis. Circulation (2002) 20.77
Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism (1981) 2.62
Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care (1994) 2.56
Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev (2008) 2.28
CD40 signaling and plaque instability. Circ Res (2001) 1.97
Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism (2009) 1.67
Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol (2009) 1.43
Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia (1986) 1.37
CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis (1998) 1.32
Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care (2008) 1.18
Studies on adrenaline-induced leucocytosis in normal man. I. The role of the spleen and of the thoracic duct. Br J Haematol (1971) 1.15
Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes (1986) 0.93
Peripheral blood cell changes in response to acute hypoglycaemia in man. Eur J Clin Invest (1983) 0.92
Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care (2000) 0.91
Effects of acute insulin-induced hypoglycaemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects. Clin Sci (Lond) (1991) 0.86
Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes. Diabet Med (2007) 0.85
Does hypoglycaemia aggravate the complications of diabetes? Lancet (1985) 0.85
Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1988) 0.82
The effect of alpha-adrenergic blockade on responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans. Eur J Clin Invest (1990) 0.81
Diurnal variation in serum remnant-like lipoproteins, platelet aggregation and fibrinolysis in healthy volunteers. Haemostasis (1998) 0.81
Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med (2007) 4.98
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med (2005) 4.93
Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation (2005) 4.71
Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med (2008) 4.57
Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care (2003) 4.23
Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study. Heart (2013) 3.94
Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet (2013) 3.57
Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA (2011) 3.56
Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem (2006) 3.24
Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol (2005) 3.12
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol (2012) 3.03
Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med (2008) 3.00
Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care (2005) 2.91
Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med (2008) 2.84
lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Clin Cancer Res (2008) 2.79
Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC "diet trials". BMJ (2006) 2.68
Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood (2007) 2.67
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med (2007) 2.65
Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ (2004) 2.47
Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol (2010) 2.32
Diabetes and cognitive dysfunction. Lancet (2012) 2.32
Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension (2006) 2.29
Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev (2008) 2.28
The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol (2010) 2.22
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells. Cancer Immunol Immunother (2008) 2.21
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation (2011) 2.21
Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg (2010) 2.06
An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol (2008) 2.06
Asthma as a barrier to children's physical activity: implications for body mass index and mental health. Pediatrics (2006) 2.05
Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease. Environ Health Perspect (2012) 2.05
Snacks containing whey protein and polydextrose induce a sustained reduction in daily energy intake over 2 wk under free-living conditions. Am J Clin Nutr (2014) 2.03
Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ (2012) 2.02
The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol (2004) 2.02
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes (2003) 1.97
Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J (2008) 1.96
Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.87
Diesel exhaust inhalation does not affect heart rhythm or heart rate variability. Heart (2010) 1.84
Combustion-derived nanoparticulate induces the adverse vascular effects of diesel exhaust inhalation. Eur Heart J (2011) 1.79
An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care (2007) 1.77
Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr (2005) 1.77
Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv (2010) 1.75
Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care (2005) 1.72
Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med (2005) 1.72
Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care (2004) 1.71
Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J (2007) 1.68
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy. J Am Coll Cardiol (2002) 1.67
Diabetes and driving. Diabetes Care (2012) 1.66
A 90-day oral gavage toxicity study of D-methylphenidate and D,L-methylphenidate in Sprague-Dawley rats. Toxicology (2002) 1.62
Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr (2005) 1.60
Hypoglycaemia and cognitive function. Diabetes Obes Metab (2005) 1.53
Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol (2012) 1.52
Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl (2008) 1.52
Plasma microparticles and vascular disorders. Br J Haematol (2007) 1.52
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro. Microvasc Res (2005) 1.52
Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease. Clin Sci (Lond) (2006) 1.51
Non-invasive measurement of cardiac output in patients with chronic heart failure. Blood Press Monit (2004) 1.51
Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. J Am Coll Cardiol (2008) 1.47
Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc (2010) 1.47
Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes (2002) 1.46
Reduced vascular complications and length of stay with transradial rescue angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.46
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46
Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension (2009) 1.46
Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. Am Heart J (2004) 1.45
Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ Health Perspect (2008) 1.45
Insulin analogues and other developments in insulin therapy for diabetes. Expert Opin Pharmacother (2003) 1.45
Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol (2009) 1.45
Characterisation and reproducibility of a human ex vivo model of thrombosis. Thromb Res (2010) 1.43
The constituents and mechanisms of generation of 'endothelial cell--colony forming units'. Cardiovasc Res (2013) 1.41
Costs of managing severe hypoglycaemia in three European countries. J Med Econ (2009) 1.40
Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Thromb Res (2005) 1.39
Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care (2003) 1.36
Breakfast consumption affects appetite, energy intake, and the metabolic and endocrine responses to foods consumed later in the day in male habitual breakfast eaters. J Nutr (2011) 1.35
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2009) 1.34
Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ Cardiovasc Imaging (2011) 1.33
Vascular effects of apelin in vivo in man. J Am Coll Cardiol (2008) 1.33
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging (2012) 1.32
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2010) 1.32
Air pollution and atherothrombosis. Inhal Toxicol (2007) 1.30
The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord (2008) 1.30
A short history of the polymerase chain reaction. Methods Mol Biol (2003) 1.30
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. Clin Cancer Res (2008) 1.29
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging (2012) 1.29
Direct impairment of vascular function by diesel exhaust particulate through reduced bioavailability of endothelium-derived nitric oxide induced by superoxide free radicals. Environ Health Perspect (2008) 1.25
Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax (2011) 1.25
Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol (2005) 1.24
Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol (2011) 1.24
Exposure to nitrogen dioxide is not associated with vascular dysfunction in man. Inhal Toxicol (2010) 1.23
Heat and haze: a forecast for myocardial infarction? Heart (2009) 1.22
Fat oxidation before and after a high fat load in the obese insulin-resistant state. J Clin Endocrinol Metab (2006) 1.21
Impaired vascular function after exposure to diesel exhaust generated at urban transient running conditions. Part Fibre Toxicol (2010) 1.20
Particle traps prevent adverse vascular and prothrombotic effects of diesel engine exhaust inhalation in men. Circulation (2011) 1.19
Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol (2003) 1.18